BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Yissum Ltd. 

Research Development Company
of The Hebrew University of Jerusalem Ltd.

High-Tech Park, Edmond J. Safra Campus
Givat Ram, P.O. Box 39135

Jerusalem    91390  Israel
Phone: 972-2-658-6693 Fax: 972-2-658-6689


SEARCH JOBS




Industry
Services






 Company News
Yissum Ltd. Introduces a Novel Method for Diagnosing Retinal Micro-Aneurysms to Prevent Diabetic Retinopathy 6/10/2013 9:57:35 AM    More...
Yissum Ltd. Announces Formation of Integra Holdings, a Biopharmaceutical Holding Company 10/31/2012 7:41:42 AM    More...
Yissum Ltd. Signs Licensing Agreement with Dow AgroFresh for a Novel Water-Soluble Compound that Antagonizes the Action of the Plant Hormone Ethylene 3/5/2012 7:56:04 AM    More...
Yissum Ltd. to Collaborate with BioConnections for the Commercialization of Kits for Identifying Antibiotic Resistant Infections 2/27/2012 6:12:37 AM    More...
Yissum Ltd. Introduces a Novel Technology for Manufacturing an Anti-Malaria Drug in Tobacco 12/19/2011 6:22:08 AM    More...
Yissum Ltd. Out-Licenses a Breakthrough Seed Improvement Technology to Morflora 11/2/2011 8:00:02 AM    More...
Yissum Ltd. Introduces Novel Markers for Brain Cancer Survival Prognosis and a New Treatment Method for the Disease 7/28/2011 7:54:37 AM    More...
BioLineRx Ltd. Signs Exclusive License Agreement with Yissum Ltd. for Oral Phase II Ready Treatment BL-7040 for Inflammatory Bowel Disease 6/27/2011 9:20:14 AM    More...
Yissum Ltd. Presents a Virtual Cane for the Visually Impaired 6/21/2011 9:19:15 AM    More...
Yissum Ltd. Presents Promising Pre-Clinical Results for Oral Delivery of the Anti-Cancer Drug Docetaxel Using a Novel Nanotechnology Approach 4/12/2011 12:14:56 PM    More...
1234